A-Myb Antibody - #AF9007

Fig. 1: Upregulation of MYBL1 correlates with high EV density and associates with HCC patient prognosis. A IHC staining indicating the MYBL1 and CD31 protein expression in para-tumor tissues and HCC tissues. B MYBL1 were positively correlated with CD31 protein levels in clinical specimens. C Patients with high MYBL1 expression (left), CD31 density (middle), and both MYBL1 and CD31 expression (right) show progression-free survival in HCC patients. D The correlation analysis between the mRNA levels of MYBL1 and angiogenesis in TCGA datasets.

Fig. 2 Different expression of MYBL1, ARHGAP30 and FAM20A was observed in GSE28829, GSE43292 and GSE41571 datasets (A) The intersection of differentially expressed genes of GSE28829, GSE43292 and GSE41571 datasets was selected. (B) Heat map of MYBL1, ARHGAP30 and FAM20A genes in early and late atherosclerotic tissues. (C-E) GEPIA analysis of the three genes MYBL1, ARHGAP30, and FAM20A was performed to obtain box plots of their expression. (F) Immumohistochemical staining was used to determine the protein expression of MYBL1 in advanced atherosclerotic plaques (AA) and normal atherosclerotic plaques (NA) (n = 8). Scale bars = 200 μm or 20 μm. (G)The protein expression of MYBL1 was detected by western blot in early atherosclerosis and advanced atherosclerosis (n = 8). (H) The quantitative analysis of MYBL1 protein expression in early atherosclerosis and advanced atherosclerosis were shown. *p